CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.
CNS Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.
CNS Pharmaceuticals | EFFECT: Others
CNS Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Cortice Biosciences, Inc.(5.7%)
CNS Pharmaceuticals | RW: Registration Withdrawal Request
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 424B3: Prospectus
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 424B5: Prospectus
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
CNS Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
CNS Pharmaceuticals | 8-K/A: Current report (Amendment)
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 424B5: Prospectus
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Forster(0%)
CNS Pharmaceuticals | 424B5: Prospectus
No Data